Supraventricular tachycardia (SVT) often goes undiagnosed due to subtle or intermittent symptoms. Learn why it’s missed and ...
FDA approval for RAPIBLYK® (landiolol) for use in pediatric patients with SVT provides first therapeutic option for these ...
RAPIBLYK (R) is an ultra-short-acting, selective beta-1 adrenergic receptor blocker administered intravenously in a monitored hospital setting. Its pharmacological profile allows for rapid onset and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results